Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The trial will include 5000 patients with evident or suspected ischemic heart disease refered to Department of Nuclear Medicine & PET Centre, Aarhus University Hospital, for perfusion imaging by 15O-H2O PET/CT scan of the heart during rest and stress. The patients will undergo the clinical scan as normal.
Data from the scans will be used to determine reference values of the examination.
Follow up will be done for up to 10 years in regards to major cardiovascular events in order to determine the prognostic value of the scan.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Prognostic value within 10 years | Number of participants who experience a major adverse cardiac event within 10 years of follow-up. | 10 years |
| Measure | Description | Time Frame |
|---|---|---|
| Myocardial blood flow | The myocardial blood flow of participants assessed by 15O-H2O PET/CT | 5 Years |
| Coronary flow reserve | The coronary flow reserve of participants assessed by 15O-H2O PET/CT |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Any patient with known or suspected ischemic heart disease referred for a clinical H2O-PET at Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, not meeting any exclusion criteria will be enrolled in the study.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Simon Madsen, MD | Contact | 4520140596+ | simmas@rm.dk |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Recruiting | Aarhus | Aarhus N | 8200 | Denmark |
Not provided
| ID | Term |
|---|---|
| D017202 | Myocardial Ischemia |
| D003324 | Coronary Artery Disease |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
| D014652 | Vascular Diseases |
| D003327 | Coronary Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
| 5 Years |
| Pulmonary transit time | The pulmonary transit time of participants assessed by 15O-H2O PET/CT | 5 Years |
| Left ventricular end-systolic volume | The left ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT | 5 Years |
| Left ventricular end-diastolic volume | The left ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT | 5 Years |
| Right ventricular end-systolic volume | The right ventricular end-systolic volume of participants assessed by 15O-H2O PET/CT | 5 Years |
| Right ventricular end-diastolic volume | The right ventricular end-diastolic volume of participants assessed by 15O-H2O PET/CT | 5 Years |
| Immediate coronary angiography followup | Number of participants who undergo coronary angiography within 3 months after primary 15O-H2O PET/CT | 5 years |
| Immediate percutaneous coronary intervention (PCI) followup | Number of participants who undergo percutaneous coronary intervention within 3 months after primary 15O-H2O PET/CT | 5 years |
| Immediate coronary artery bypass graft (CABG) followup | Number of participants who undergo coronary artery bypass graft within 3 months after primary 15O-H2O PET/CT | 5 years |
| Prognostic value within 5 years | Number of participants who experience a major adverse cardiac event within 5 years of follow-up. | 5 years |
| Prognostic value within 2 years | Number of participants who experience a major adverse cardiac event within 2 years of follow-up. | 2 years |
| Prognostic value within 1 years | Number of participants who experience a major adverse cardiac event within 1 years of follow-up. | 1 years |
| D001161 |
| Arteriosclerosis |
| D001157 | Arterial Occlusive Diseases |